Patents by Inventor Magali B. HICKEY

Magali B. HICKEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions having improved storage stability
    Patent number: 11969469
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent.
    Type: Grant
    Filed: August 10, 2021
    Date of Patent: April 30, 2024
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, Jr., Zhengzheng Pan
  • PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS
    Publication number: 20240131024
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Application
    Filed: October 31, 2023
    Publication date: April 25, 2024
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver
  • Aripiprazole formulations having increased injection speeds
    Patent number: 11931355
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Grant
    Filed: June 29, 2022
    Date of Patent: March 19, 2024
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • Pharmaceutical Compositions Comprising Sorbitan Esters
    Publication number: 20240058327
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Application
    Filed: March 14, 2023
    Publication date: February 22, 2024
    Inventors: Jason M. PERRY, Daniel R. DEAVER, Magali B. HICKEY, Julius F. REMENAR, Jennifer VANDIVER
  • ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS
    Publication number: 20230026422
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Application
    Filed: June 29, 2022
    Publication date: January 26, 2023
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • Aripiprazole formulations having increased injection speeds
    Patent number: 11406632
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Grant
    Filed: June 1, 2020
    Date of Patent: August 9, 2022
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • Pharmaceutical Compositions Having Improved Storage Stability
    Publication number: 20220072133
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent
    Type: Application
    Filed: August 10, 2021
    Publication date: March 10, 2022
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, JR., Zhengzheng Pan
  • Pharmaceutical compositions having improved storage stability
    Patent number: 11097006
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent
    Type: Grant
    Filed: March 30, 2020
    Date of Patent: August 24, 2021
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, Jr., Zhengzheng Pan
  • Aripiprazole formulations having increased injection speeds
    Patent number: 10813928
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: October 27, 2020
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS
    Publication number: 20200289504
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Application
    Filed: June 1, 2020
    Publication date: September 17, 2020
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • Pharmaceutical Compositions Having Improved Storage Stability
    Publication number: 20200268891
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent
    Type: Application
    Filed: March 30, 2020
    Publication date: August 27, 2020
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, JR., Zhengzheng Pan
  • Pharmaceutical compositions having improved storage stability
    Patent number: 10639376
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: May 5, 2020
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, Jr., Zhengzheng Pan
  • Pharmaceutical Compositions Having Improved Storage Stability
    Publication number: 20190275155
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent
    Type: Application
    Filed: May 29, 2019
    Publication date: September 12, 2019
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, JR., Zhengzheng Pan
  • Pharmaceutical Compositions Comprising Sorbitan Esters
    Publication number: 20190216805
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Application
    Filed: January 15, 2019
    Publication date: July 18, 2019
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver
  • Pharmaceutical compositions having improved storage stability
    Patent number: 10342877
    Abstract: The present invention relates to a pharmaceutical composition that provides long-term stability of a hydrolytically labile antipsychotic agent.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: July 9, 2019
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver, Michael J. Palmieri, Jr., Zhengzheng Pan
  • ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS
    Publication number: 20190167673
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Application
    Filed: February 8, 2019
    Publication date: June 6, 2019
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • Aripiprazole formulations having increased injection speeds
    Patent number: 10238651
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: March 26, 2019
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • Pharmaceutical compositions comprising sorbitan esters
    Patent number: 10226458
    Abstract: The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: March 12, 2019
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Jason M. Perry, Daniel R. Deaver, Magali B. Hickey, Julius F. Remenar, Jennifer Vandiver
  • ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS
    Publication number: 20180369239
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Application
    Filed: August 29, 2018
    Publication date: December 27, 2018
    Inventors: Magali B. Hickey, Jennifer Vandiver
  • Aripiprazole formulations having increased injection speeds
    Patent number: 10085980
    Abstract: The present invention relates to pharmaceutical compositions comprising a compound of Formula (I) that are useful for the intramuscular delivery of antipsychotic drugs using rapid injection rates.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: October 2, 2018
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Magali B. Hickey, Jennifer Vandiver